Leisha Emens

Associate Professor

1992 …2018
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 15 Similar Profiles
Cancer Vaccines Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Granulocyte-Macrophage Colony-Stimulating Factor Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Immunity Medicine & Life Sciences
Vaccines Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2018

Breast cancer immunotherapy: Facts and hopes

Emens, L. A., Feb 1 2018, In : Clinical Cancer Research. 24, 3, p. 511-520 10 p.

Research output: Contribution to journalReview article

Breast Neoplasms
CD274 Antigen
Triple Negative Breast Neoplasms

Development of Anti-Human Mesothelin-Targeted Chimeric Antigen Receptor Messenger RNA-Transfected Peripheral Blood Lymphocytes for Ovarian Cancer Therapy

Hung, C. F., Xu, X., Li, L., Ma, Y., Jin, Q., Viley, A., Allen, C., Natarajan, P., Shivakumar, R., Peshwa, M. V. & Emens, L. A., May 1 2018, In : Human Gene Therapy. 29, 5, p. 614-625 12 p.

Research output: Contribution to journalArticle

Antigen Receptors
Human Development
Ovarian Neoplasms
Messenger RNA

Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients with Metastatic Triple-Negative Breast Cancer: A Phase 1 Study

Emens, L. A., Cruz, C., Eder, J. P., Braiteh, F., Chung, C., Tolaney, S. M., Kuter, I., Nanda, R., Cassier, P. A., Delord, J. P., Gordon, M. S., Elgabry, E., Chang, C. W., Sarkar, I., Grossman, W., O'Hear, C., Fassò, M., Molinero, L. & Schmid, P., Jan 1 2018, (Accepted/In press) In : JAMA Oncology.

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms
Cell Death

Racial disparities in the rate of cardiotoxicity of HER2-targeted therapies among women with early breast cancer

Litvak, A., Batukbhai, B., Russell, S. D., Tsai, H. L., Rosner, G. L., Jeter, S. C., Armstrong, D., Emens, L. A., Fetting, J., Wolff, A. C., Silhy, R., Stearns, V. & Connolly, R. M., Jan 1 2018, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

Breast Neoplasms
Confidence Intervals
Stroke Volume

STING signaling: A key to therapeutic tumor immunity

Foote, J. B. & Emens, L. A., Jul 1 2018, In : Immunotherapy. 10, 9, p. 729-731 3 p.

Research output: Contribution to journalReview article